Print

NeuroTherapeutics Pharma Receives Investment from the Epilepsy Therapy Project  
11/10/2009 9:29:45 AM

CHICAGO--(BUSINESS WIRE)--NeuroTherapeutics Pharma, Inc., or NTP, a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, today announced that it received a $100,000 investment from the Epilepsy Therapy Project.
//-->